Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Knox

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Cytogenetics and Cell Genetics|January 1, 1996
Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22J D Knox, D R Boreham, J A Walker, et al.
The Journal of the Royal College of General Practitioners|November 1, 1981
Duplicate prescriptions: an aid to research and reviewJ G Hamley, S V Brown, J Crooks, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 27, 2004
Novel role of phospholipase C-delta1: regulation of liver mitochondrial Ca2+ uptakeClayton D Knox, Andrey E Belous, Janene M Pierce, et al.
Lancet (London, England)|April 25, 1970
Medical computing: a reappraisalR S Buxton, T Crawford, A C Cunliffe, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 14, 2007
2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptakeI B Nicoud, C D Knox, C M Jones, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 11, 2004
Survival and functional quality of life after resection for hepatic carcinoid metastasisClayton D Knox, Irene D Feurer, Paul E Wise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid TumorsAndrew J Wagner, Udai Banerji, Amit Mahipal, et al.
Leukemia Research|August 22, 2016
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)Farhad Ravandi, Ivana Gojo, Mrinal M Patnaik, et al.
Annals of Surgical Oncology|January 10, 2015
Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 casesRobert D Knox, Nathan Luey, Loretta Sioson, et al.
Journal of the American Heart Association|August 27, 2016
Discovery and Clinical Evaluation of MK-8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide ReleaseClayton D Knox, Pieter-Jan de Kam, Karim Azer, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Cytogenetics and Cell Genetics|January 1, 1996
Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22J D Knox, D R Boreham, J A Walker, et al.
The Journal of the Royal College of General Practitioners|November 1, 1981
Duplicate prescriptions: an aid to research and reviewJ G Hamley, S V Brown, J Crooks, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 27, 2004
Novel role of phospholipase C-delta1: regulation of liver mitochondrial Ca2+ uptakeClayton D Knox, Andrey E Belous, Janene M Pierce, et al.
Lancet (London, England)|April 25, 1970
Medical computing: a reappraisalR S Buxton, T Crawford, A C Cunliffe, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 14, 2007
2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptakeI B Nicoud, C D Knox, C M Jones, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 11, 2004
Survival and functional quality of life after resection for hepatic carcinoid metastasisClayton D Knox, Irene D Feurer, Paul E Wise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid TumorsAndrew J Wagner, Udai Banerji, Amit Mahipal, et al.
Leukemia Research|August 22, 2016
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)Farhad Ravandi, Ivana Gojo, Mrinal M Patnaik, et al.
Annals of Surgical Oncology|January 10, 2015
Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 casesRobert D Knox, Nathan Luey, Loretta Sioson, et al.
Journal of the American Heart Association|August 27, 2016
Discovery and Clinical Evaluation of MK-8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide ReleaseClayton D Knox, Pieter-Jan de Kam, Karim Azer, et al.
Pageof 16